{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:22:50Z","timestamp":1722889370242},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T00:00:00Z","timestamp":1404864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s10840-014-9924-9","type":"journal-article","created":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T05:53:46Z","timestamp":1404798826000},"page":"107-116","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation"],"prefix":"10.1007","volume":"41","author":[{"name":"on behalf of the VENTURE-AF Investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald V.","family":"Naccarelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Cappato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan H.","family":"Hohnloser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis E.","family":"Marchlinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Wilber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changsheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Wyn","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry E.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Natale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,9]]},"reference":[{"issue":"10","key":"9924_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrcardio.2013.121","volume":"10","author":"J Dewire","year":"2013","unstructured":"Dewire, J., & Calkins, H. (2013). Update on atrial fibrillation catheter ablation technologies and techniques. Nature Reviews Cardiology, 10(10), 599\u2013612.","journal-title":"Nature Reviews Cardiology"},{"issue":"8","key":"9924_CR2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991). Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke, 22(8), 983\u2013988.","journal-title":"Stroke"},{"key":"9924_CR3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1749-6632.2012.06494.x","volume":"1254","author":"JS Chinitz","year":"2012","unstructured":"Chinitz, J. S., Castellano, J. M., Kovacic, J. C., & Fuster, V. (2012). Atrial fibrillation, stroke, and quality of life. Annals of the New York Academy of Sciences, 1254, 140\u2013150.","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5","key":"9924_CR4","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ijcard.2012.12.093","volume":"167","author":"J Ball","year":"2013","unstructured":"Ball, J., Carrington, M. J., McMurray, J. J., & Stewart, S. (2013). Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. International Journal of Cardiology, 167(5), 1807\u20131824.","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"9924_CR5","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.ijcard.2013.01.184","volume":"167","author":"TN Nguyen","year":"2013","unstructured":"Nguyen, T. N., Hilmer, S. N., & Cumming, R. G. (2013). Review of epidemiology and management of atrial fibrillation in developing countries. International Journal of Cardiology, 167(6), 2412\u20132420.","journal-title":"International Journal of Cardiology"},{"issue":"4","key":"9924_CR6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3949\/ccjm.78a.09165","volume":"78","author":"T Callahan","year":"2011","unstructured":"Callahan, T., & Baranowski, B. (2011). Managing newly diagnosed atrial fibrillation: rate, rhythm, and risk. Cleveland Clinic Journal of Medicine, 78(4), 258\u2013264.","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"1","key":"9924_CR7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjcard.2013.02.056","volume":"112","author":"YY Zhang","year":"2013","unstructured":"Zhang, Y. Y., Qiu, C., Davis, P. J., Jhaveri, M., Prystowsky, E. N., Kowey, P., et al. (2013). Predictors of progression of recently diagnosed atrial fibrillation in Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation (RecordAF)-United States cohort. American Journal of Cardiology, 112(1), 79\u201384.","journal-title":"American Journal of Cardiology"},{"issue":"21","key":"9924_CR8","first-page":"2719","volume":"33","author":"AJ Camm","year":"2010","unstructured":"Camm, A. J., Lip, G. Y., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., et al. (2010). 2012 focused update of the ESC. Developed with the special contribution of the European Heart Rhythm Association. Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. European Heart Journal, 33(21), 2719\u20132747. Erratum in (2013) European Heart Journal, 34(10), 790.","journal-title":"European Heart Journal"},{"issue":"1","key":"9924_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/WCO.0b013e32834e604a","volume":"25","author":"HC Diener","year":"2012","unstructured":"Diener, H. C., Weber, R., Lip, G. Y., & Hohnloser, S. H. (2012). Stroke prevention in atrial fibrillation: do we still need warfarin? Current Opinion in Neurology, 25(1), 27\u201335.","journal-title":"Current Opinion in Neurology"},{"issue":"3","key":"9924_CR10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ahj.2013.04.009","volume":"166","author":"SE Kimmel","year":"2013","unstructured":"Kimmel, S. E., French, B., Anderson, J. L., Gage, B. F., Johnson, J. A., Rosenberg, Y. D., et al. (2013). Rationale and design of the clarification of optimal anticoagulation through genetics trial. American Heart Journal, 166(3), 435\u2013441.","journal-title":"American Heart Journal"},{"issue":"10","key":"9924_CR11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., et al. (2011). Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New England Journal of Medicine, 365(10), 883\u2013895.","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"9924_CR12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1538-7836.2005.01166.x","volume":"3","author":"E Perzborn","year":"2005","unstructured":"Perzborn, E., Strassburger, J., Wilmen, A., Pohlmann, J., Roehrig, S., Schlemmer, K. H., et al. (2005). In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939\u2014an oral, direct factor Xa inhibitor. Journal of Thrombosis and Haemostasis, 3(3), 514\u2013521.","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"3","key":"9924_CR13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11239-012-0727-5","volume":"34","author":"SM Ringwala","year":"2012","unstructured":"Ringwala, S. M., Dibattiste, P. M., & Schneider, D. J. (2012). Effects on platelet function of a direct acting antagonist of coagulation factor Xa. Journal of Thrombosis and Thrombolysis, 34(3), 291\u2013296.","journal-title":"Journal of Thrombosis and Thrombolysis"},{"issue":"19","key":"9924_CR14","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.113.003862","volume":"128","author":"A Deshmukh","year":"2013","unstructured":"Deshmukh, A., Patel, N. J., Pant, S., et al. (2013). In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation, 128(19), 2104\u20132112.","journal-title":"Circulation"},{"issue":"1","key":"9924_CR15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/CIRCEP.109.859116","volume":"3","author":"R Cappato","year":"2010","unstructured":"Cappato, R., Calkins, H., Chen, S. A., et al. (2010). Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation Arrhythmia Electrophysiology, 3(1), 32\u201338.","journal-title":"Circulation Arrhythmia Electrophysiology"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-014-9924-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-014-9924-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-014-9924-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T02:04:11Z","timestamp":1559268251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-014-9924-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,9]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["9924"],"URL":"https:\/\/doi.org\/10.1007\/s10840-014-9924-9","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"type":"print","value":"1383-875X"},{"type":"electronic","value":"1572-8595"}],"subject":[],"published":{"date-parts":[[2014,7,9]]}}}